COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Atea Pharmaceuticals Inc |
0.00 |
0.00% |
0.00 % |
0.00 % |
Johnson and Johnson |
89,331.00 |
14.19% |
14.32% |
13.80% |
Merck and Co Inc |
63,922.00 |
10.16% |
10.16% |
9.58% |
Pfizer Inc |
62,463.00 |
9.92% |
8.97% |
10.89% |
Abbvie Inc |
57,367.00 |
9.11% |
8.73% |
9.26% |
Sanofi |
49,599.72 |
7.88% |
7.88% |
0.00% |
Eli Lilly And Company |
49,003.20 |
7.79% |
8.33% |
8.29% |
Bristol myers Squibb Company |
47,636.00 |
7.57% |
7.33% |
7.56% |
Novartis Ag |
46,660.00 |
7.41% |
7.41% |
0.00% |
Astrazeneca Plc |
45,811.00 |
7.28% |
7.28% |
0.00% |
Takeda Pharmaceutical Company Limited |
29,166.69 |
4.63% |
4.63% |
0.00% |
Gilead Sciences Inc |
28,735.00 |
4.57% |
4.36% |
4.64% |
Regeneron Pharmaceuticals Inc |
14,085.70 |
2.24% |
1.98% |
2.32% |
Vertex Pharmaceuticals Inc |
11,099.70 |
1.76% |
1.81% |
1.78% |
Organon and Co |
6,294.00 |
1.00% |
0.99% |
0.98% |
Jazz Pharmaceuticals Plc |
4,064.81 |
0.65% |
0.59% |
0.67% |
Horizon Therapeutics Public Limited Company |
3,643.45 |
0.58% |
0.62% |
0.51% |
United Therapeutics Corporation |
2,994.10 |
0.48% |
0.52% |
0.45% |
Biomarin Pharmaceutical Inc |
2,950.23 |
0.47% |
0.49% |
0.46% |
Adhera Therapeutics Inc |
2,732.01 |
0.43% |
0.00% |
0.00% |
Alnylam Pharmaceuticals Inc |
2,348.10 |
0.37% |
0.39% |
0.36% |
Ptc Therapeutics inc |
900.03 |
0.14% |
0.00% |
0.11% |
Apellis Pharmaceuticals Inc |
775.84 |
0.12% |
0.11% |
0.13% |
Opko Health Inc |
713.14 |
0.11% |
0.12% |
0.11% |
Kiniksa Pharmaceuticals International Plc |
481.17 |
0.08% |
0.09% |
0.08% |
Arvinas Inc |
426.90 |
0.07% |
0.12% |
0.04% |
Innoviva Inc |
408.35 |
0.06% |
0.05% |
0.06% |
Evolus Inc |
380.30 |
0.06% |
0.04% |
0.11% |
Legend Biotech Corporation |
285.14 |
0.05% |
0.05% |
0.00% |
Arrowhead Pharmaceuticals Inc |
278.34 |
0.04% |
0.36% |
0.00% |
Travere Therapeutics Inc |
273.53 |
0.04% |
0.05% |
0.05% |
Galapagos Nv |
268.49 |
0.04% |
0.04% |
0.00% |
Morphosys Ag |
266.87 |
0.04% |
0.04% |
0.00% |
Esperion Therapeutics Inc |
259.57 |
0.04% |
0.04% |
0.04% |
Revance Therapeutics Inc |
247.00 |
0.04% |
0.04% |
0.04% |
Pharming Group N v |
245.10 |
0.04% |
0.00% |
0.12% |
Amarin Corp Plcuk |
214.11 |
0.03% |
0.03% |
0.04% |
Ligand Pharmaceuticals Incorporated |
181.29 |
0.03% |
0.03% |
0.03% |
Fibrogen Inc |
180.01 |
0.03% |
0.00% |
0.00% |
Cytomx Therapeutics Inc |
147.56 |
0.02% |
0.03% |
0.02% |
Kamada Ltd |
142.52 |
0.02% |
0.02% |
0.00% |
Arcus Biosciences Inc |
141.00 |
0.02% |
0.02% |
0.02% |
Prothena Corporation Public Limited Company |
137.94 |
0.02% |
0.00% |
0.00% |
Bridgebio Pharma Inc |
127.42 |
0.02% |
0.08% |
0.00% |
Xencor Inc |
127.23 |
0.02% |
0.02% |
0.03% |
Gossamer Bio Inc |
124.59 |
0.02% |
0.01% |
0.01% |
Anaptysbio inc |
111.87 |
0.02% |
0.02% |
0.03% |
Zymeworks Inc |
93.38 |
0.01% |
0.02% |
0.02% |
Optinose Inc |
90.62 |
0.01% |
0.02% |
0.01% |
Nektar Therapeutics |
87.25 |
0.01% |
0.01% |
0.02% |
Theratechnologies Inc |
81.76 |
0.01% |
0.01% |
0.00% |
Morphic Holding inc |
75.30 |
0.01% |
0.00% |
0.00% |
Theravance Biopharma inc |
65.27 |
0.01% |
0.01% |
0.01% |
Cidara Therapeutics Inc |
65.06 |
0.01% |
0.00% |
0.00% |
Enanta Pharmaceuticals Inc |
64.46 |
0.01% |
0.01% |
0.01% |
Ocular Therapeutix Inc |
59.65 |
0.01% |
0.01% |
0.01% |
Fortress Biotech Inc |
57.78 |
0.01% |
0.01% |
0.01% |
Alpine Immune Sciences Inc |
56.52 |
0.01% |
0.00% |
0.02% |
Nurix Therapeutics Inc |
56.42 |
0.01% |
0.01% |
0.01% |
Journey Medical Corp |
56.13 |
0.01% |
0.01% |
0.01% |
Integrated Biopharma Inc |
53.38 |
0.01% |
0.01% |
0.01% |
Ideaya Biosciences Inc |
49.87 |
0.01% |
0.00% |
0.00% |
Spero Therapeutics Inc |
44.58 |
0.01% |
0.00% |
0.01% |
Xoma Royalty Corporation |
42.91 |
0.01% |
0.01% |
0.01% |
Scpharmaceuticals Inc |
41.98 |
0.01% |
0.01% |
0.01% |
Cartesian Therapeutics Inc |
40.01 |
0.01% |
0.00% |
0.00% |
Mirati Therapeutics Inc |
38.19 |
0.01% |
0.01% |
0.01% |
Mereo Biopharma Group Plc |
36.46 |
0.01% |
0.00% |
0.00% |
Lexicon Pharmaceuticals Inc |
31.08 |
0.00% |
0.02% |
0.00% |
Casi Pharmaceuticals inc |
28.54 |
0.00% |
0.00% |
0.00% |
Bicycle Therapeutics Plc |
25.72 |
0.00% |
0.01% |
0.00% |
Novan Inc |
24.92 |
0.00% |
0.00% |
0.01% |
Abcellera Biologics Inc |
23.11 |
0.00% |
0.00% |
0.00% |
Cytokinetics Incorporated |
19.22 |
0.00% |
0.00% |
0.01% |
Aclaris Therapeutics Inc |
17.78 |
0.00% |
0.00% |
0.01% |
Avalo Therapeutics Inc |
17.38 |
0.00% |
0.00% |
0.00% |
Medicure Inc |
16.78 |
0.00% |
0.00% |
0.00% |
Iterum Therapeutics Plc |
14.32 |
0.00% |
0.00% |
0.00% |
Xenon Pharmaceuticals Inc |
13.17 |
0.00% |
0.00% |
0.00% |
Janux Therapeutics Inc |
13.05 |
0.00% |
0.00% |
0.00% |
Aptevo Therapeutics Inc |
12.99 |
0.00% |
0.00% |
0.00% |
Kalvista Pharmaceuticals Inc |
12.69 |
0.00% |
0.00% |
0.00% |
Immunome Inc |
12.51 |
0.00% |
0.00% |
0.00% |
Nuvation Bio Inc |
10.79 |
0.00% |
0.00% |
0.00% |
Fulcrum Therapeutics Inc |
10.72 |
0.00% |
0.00% |
0.00% |
Xilio Therapeutics inc |
9.27 |
0.00% |
0.00% |
0.00% |
Xbiotech Inc |
8.21 |
0.00% |
0.00% |
0.00% |
Pulmatrix Inc |
7.81 |
0.00% |
0.00% |
0.00% |
Dianthus Therapeutics Inc |
6.52 |
0.00% |
0.00% |
0.00% |
Spyre Therapeutics Inc |
5.81 |
0.00% |
0.00% |
0.00% |
Kala Bio inc |
5.75 |
0.00% |
0.00% |
0.00% |
Vtv Therapeutics Inc |
5.02 |
0.00% |
0.00% |
0.00% |
Qualigen Therapeutics Inc |
4.79 |
0.00% |
0.00% |
0.00% |
Ngm Biopharmaceuticals Inc |
4.42 |
0.00% |
0.00% |
0.00% |
Matinas Biopharma Holdings Inc |
4.28 |
0.00% |
0.00% |
0.00% |
Prometheus Biosciences Inc |
4.00 |
0.00% |
0.00% |
0.00% |
Clearside Biomedical Inc |
3.76 |
0.00% |
0.00% |
0.00% |
Dmk Pharmaceuticals Corporation |
3.53 |
0.00% |
0.00% |
0.00% |
Scynexis Inc |
2.63 |
0.00% |
0.00% |
0.00% |
Xenetic Biosciences Inc |
2.58 |
0.00% |
0.00% |
0.00% |
Infinity Pharmaceuticals Inc |
2.57 |
0.00% |
0.00% |
0.00% |
Palatin Technologies Inc |
2.18 |
0.00% |
0.00% |
0.00% |
Galmed Pharmaceuticals Ltd |
2.04 |
0.00% |
0.00% |
0.00% |
Humanigen Inc |
1.70 |
0.00% |
0.00% |
0.00% |
Hcw Biologics Inc |
1.45 |
0.00% |
0.00% |
0.00% |
An2 Therapeutics Inc |
1.35 |
0.00% |
0.00% |
0.00% |
Comera Life Sciences Holdings Inc |
1.10 |
0.00% |
0.00% |
0.00% |
Oculis Holding Ag |
0.88 |
0.00% |
0.00% |
0.00% |
Applied Therapeutics Inc |
0.46 |
0.00% |
0.00% |
0.00% |
Altamira Therapeutics Ltd |
0.31 |
0.00% |
0.00% |
0.00% |
Adagene Inc |
0.10 |
0.00% |
0.00% |
0.00% |
Sangui Biotech International Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Innovation1 Biotech Inc |
0.08 |
0.00% |
0.00% |
0.00% |
Inflarx N v |
0.07 |
0.00% |
0.00% |
0.00% |
Cormedix Inc |
0.07 |
0.00% |
0.02% |
0.01% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Akari Therapeutics Plc |
0.00 |
0.00% |
0.00% |
0.00% |
Aldeyra Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Allakos Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Annexon Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Apexigen Inc |
0.00 |
0.00% |
0.00% |
0.00% |
180 Life Sciences Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Astria Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Arrivent Biopharma inc |
0.00 |
0.00% |
0.00% |
0.00% |
Azitra Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Atreca inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biovie Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Belite Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Biostax Corp |
0.00 |
0.00% |
0.00% |
0.00% |
Calcimedica Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Contrafect Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Cellectar Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Centessa Pharmaceuticals Plc |
0.00 |
0.00% |
0.01% |
0.00% |
Connect Biopharma Holdings Limited |
0.00 |
0.00% |
0.00% |
0.02% |
Contineum Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cohbar Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Cytodyn inc |
0.00 |
0.00% |
0.00% |
0.00% |
Dice Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Diamedica Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Edesa Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eledon Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Eqrx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Evelo Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Forte Biosciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Galecto Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Genelux Corporation |
0.00 |
0.00% |
0.00% |
0.00% |
Structure Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gri Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Gt Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Indaptus Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Disc Medicine Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Iveric Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Kezar Life Sciences Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Lianbio |
0.00 |
0.00% |
0.00% |
0.00% |
Merrimack Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moleculin Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Mira Pharmaceuticals Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Moonlake Immunotherapeutics |
0.00 |
0.00% |
0.00% |
0.00% |
Mineralys Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nexien Biopharma Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Beigene Ltd |
0.00 |
0.00% |
0.73% |
0.00% |
Os Therapies Incoporated |
0.00 |
0.00% |
0.00% |
0.00% |
Protokinetix Incorporated |
0.00 |
0.00% |
0.00% |
0.00% |
Prelude Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Palvella Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Pyxis Oncology Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovaro Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Transcode Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Renovorx Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Acelyrin Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Third Harmonic Bio Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Tiziana Life Sciences Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Vera Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Viracta Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Xtl Biopharmaceuticals Ltd |
0.00 |
0.00% |
0.00% |
0.00% |
Zyversa Therapeutics Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Nanoviricides inc |
0.00 |
0.00% |
0.00% |
0.00% |
Sellas Life Sciences Group Inc |
-0.28 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
629,406.27 |
100% |
152,833.89 |
100% |